期刊文献+

康复新液联合胶体果胶铋或(和)奥美拉唑治疗胃溃疡有效性和安全性比较 被引量:24

A randomized,controlled study in the treatment of gastrohelcoma using Kangfuxin liquid combined with colloidal bismuth PECT in-739 and/or omeprazole
原文传递
导出
摘要 [目的]比较康复新液联合胶体果胶铋或(和)奥美拉唑治疗胃溃疡(GU)有效性和安全性。[方法]278例GU患者连续随机地分为:康复新组(A组);康复新+胶体果胶铋组(B组);康复新+奥美拉唑组(C组);康复新+胶体果胶铋+奥美拉唑组(D组)。A组口服康复新治疗,B组在A组的基础上加服胶体果胶铋,C组在A组的基础上加服奥美拉唑;D组在B组的基础上加服奥美拉唑。治疗4周后观察4组患者的腹痛、上腹胀、恶心、呕吐、纳差嗳气、反酸、烧心(或胸骨后烧灼感)等情况及不良反应。[结果]A、B、C、D组治疗后恶心、呕吐改善总有效率分别为50.72%、72.22%、50.74%、75.71%,B、D组与A组,C组与D组比较均差异有统计学意义(P<0.05);A、B、C、D组治疗后腹痛、腹胀改善总有效率分别为52.17%、68.06%、65.67%、95.71%,A、B、C组与D组比较均差异有统计学意义(P<0.05),A组与B组、A组与C组比较差异无统计学意义(P>0.05);A、B、C、D组治疗后反酸、烧心改善总有效率分别为53.62%、80.56%、52.24%、87.14%,B、D组与A组,C组与D组比较均差异有统计学意义(P<0.05)。[结论]单用康复新对GU是有效的,适合轻中度GU;联合胶体果胶铋对GU更有效,适合较重的GU患者;再联合奥美拉唑对于GU最有效,特别适合重型GU患者。 [ Objective ] To compare the efficacy and safety of Kangfuxin Liquid combined with Colloidal Bismuth PECTin-739and / or Omeprazole in the treatment of gastric benign ulcer(GU).[ Methods ] A total of 278consecutive outpatients with GU were randomly divided into the following groups : group A treated with Kangfuxin Liquid,group B treated with Kangfuxin Liquid combined with Colloidal Bismuth PEC Tin739,group C treated with Kangfuxin Liquid combined with Omeprazole,and group D treated with Kangfuxin Liquid combined with Colloidal Bismuth PECTin-739and Omeprazole.Four weeks after treatment,the patients ’ symptoms such as bellyache,epigastric distension,nausea,vomiting,sour regurgitation,heartburn as well as the adverse reactions were observed and recorded.[ Results ] The total effective rates for nausea and vomiting were 50.72%,72.22%,50.74%,and 75.71%.,respectively in group A,B,C,and D after treatment,and the difference between group A and group B,group A and group D,group C and group D was statistically significant(P 0.05).The total effective rates for bellyache and epigastric distension were 52.17%,68.06%,65.67%,and 95.71% respectively in group A,B,C,and D after treatment.There were significant differences between group A,B,C and group D(P 0.05) The difference between group A and group B or group A and group C was insignificant(P 0.05) The total effective rates for sour regurgitation and heartburn were 53.62%,80.56%,52.24%,and 87.14%,respectively in group A,B,C,and D after treatment.The differences between group A and group B,between group A and group D,and between group C and group D were statistically significant(P 0.05).[ Conclusion ] Kangfuxin Liquid was effective,suitable for mild GU.Kangfuxin Liquid combined with Colloidal Bismuth PECTin-739has better effect on medium GU.Kangfuxin Liquid combined with Colloidal Bismuth PECTin739and / or Omeprazole is the most effective for GU,especially for severe GU.
出处 《中国中西医结合消化杂志》 CAS 2013年第7期356-359,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
关键词 胃溃疡 康复新液 胶体果胶铋 奥美拉唑 gastric benign ulcer Kangfuxin Liquid Colloidal Bismuth PECTin-739 Omeprazole
  • 相关文献

参考文献5

二级参考文献19

  • 1瞿丽,陈辉,叶金明.康复新在老年慢性溃疡患者中的应用[J].华西药学杂志,2004,19(6):483-483. 被引量:37
  • 2MALFERTHEINER P,MEGERAUD F,O'morain C,et al.Curent concepts in management of Helicobacter pylori infection-The Maastrieht 2-2000 consensus report[J].Aliment Pharmacol Ther,2002,16:167.
  • 3MALFERTHEINER P,PEITZ U,TREIBER G.What constitutes failme for helicobaeter pylori eraication therapy[J].Can J Gastroenterol,2003,17(Suppl B):53B.
  • 4WANG WH,WONG BC,MUKHOPADHYAY AK,et al.High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong[J].Aliment Pharmacol Ther,2000,14:901.
  • 5SANCHEZ JE,SAENZ NG,RINCON MR,et al.Susceptibility of Helicobacter pylori to mupiroein,oxazolidinones,quinupristin/dalfopristin and new quinolonas[J].J Antimicrob Chemother,2000,46:283.
  • 6XIA HH,YU WONG BC,TALLEY NJ,et al.Alternative and rescure treatment regimens for Helicobacter pylori eradication[J].Expert Opin Pharmaeother,2002,3:1301.
  • 7WATANABE Y,AOYAMA N,SHIRASAKA D,et al.Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy[J].Dig Liver Dis,2003,35:711.
  • 8SPINZI GC,BIERTI L,BORTOLI A,et al.Comparison of omeprazole and lansoprazole in short time triple therapy for helicobacter pylori[J].Aliment Pharmacol Ther,1998,12:433.
  • 9冯韶燕,洪海裕,樊韵平,王静清.康复新液应用在扁桃体切除术后的临床疗效[J].华西药学杂志,2007,22(4):461-462. 被引量:14
  • 10叶任高,陆再英.内科学,北京[M].人民卫生出版社.2006.116-117.

共引文献692

同被引文献167

引证文献24

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部